These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1877328)

  • 21. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of local thrombolysis with special reference to diabetic metabolism].
    Stiegler H; Hufen V; Weichenhain B; Standl E; Mehnert H
    Med Klin (Munich); 1990 Apr; 85(4):171-5, 228. PubMed ID: 2352521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
    Heidrich H
    Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
    Ranke C; Creutzig A; Alexander K
    Med Klin (Munich); 1991 Jul; 86(7):349-52, 382. PubMed ID: 1921896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
    Neumann FJ; Diehm C; Müller-Bühl U; Weiss T; Zimmermann R; Tillmanns H; Kübler W
    Vasa Suppl; 1989; 27():40-1. PubMed ID: 2623539
    [No Abstract]   [Full Text] [Related]  

  • 31. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis.
    Wölfle KD; Bruijnen H; Loeprecht H; Rümenapf G; Schweiger H; Grabitz K; Sandmann W; Lauterjung L; Largiader J; Erasmi H; Kasprzak PM; Raithel D; Allenberg JR; Lauber A; Berlakovich GM; Kretschmer G; Hepp W; Becker HM; Schulz A
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):229-34. PubMed ID: 12623334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intra-arterial infusion therapy of progressive diabetic foot gangrene with prostaglandin E1 amd cefotaxime].
    Krawzak HW; Jäkel F; Strosche H; Buchholz J
    Vasa; 1989; 18(4):312-5. PubMed ID: 2609738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of prostaglandin El on hemodynamics and metabolism of the extremities in healthy humans and patients with stage III and IV arterial occlusive disease].
    Rexroth W; Amendt K; Römmele U; Stein U; Wagner E; Hild R
    Vasa; 1985; 14(3):220-4. PubMed ID: 4050061
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacologic concepts for clinical use of prostaglandin E1].
    Schrör K
    Vasa Suppl; 1991; 33():335-6. PubMed ID: 1788746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
    Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
    Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
    Sinzinger H; Rogatti W
    Wien Klin Wochenschr; 1991; 103(18):558-65. PubMed ID: 1750223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA; de la Haye R; Rettig K; Kuntz G
    Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostaglandin E1 in decreased arterial perfusion].
    Pilger E; Bertuch H; Stark G; Hönigl K
    Wien Klin Wochenschr; 1988 Jul; 100(14):490-5. PubMed ID: 3062908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
    Heidrich H; Brodel C; Meuche C; Hellmann M; Ranft J
    Vasa; 1991; 20(1):13-6. PubMed ID: 2031393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.